Antinuclear antibodies in neurology and their clinical application-Reference-Cited by-同舟云学术

Antinuclear antibodies in neurology and their clinical application

Published:2021-12-01 Issue: Volume: Page:
ISSN:1460-2725
Container-title:QJM: An International Journal of Medicine
language:en
Short-container-title:

Author:

Sudheer Pachipala¹,Agarwal Ayush¹^ORCID,Vishnu Venugopalan Y¹^ORCID

Affiliation:

1. From the Department of Neurology, All India Institute of Medical Sciences, New Delhi, 110029 India

Abstract

Abstract Antinuclear antibodies (ANA) are a diverse group of autoantibodies found in various systemic autoimmune disorders. They represent a key diagnostic marker in the diagnosis of connective tissue disorders (CTD). Although many techniques exist, ANA by indirect immunofluorescence remains the gold standard for diagnosing CTDs. Neurologists should be aware of the type of assay used for detection and the advantages and disadvantages of using each method. Through this article, we aimed to review the methodological aspects of the detection of ANA and its subtypes and their clinical relevance in various neurologic disorders.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://academic.oup.com/qjmed/advance-article-pdf/doi/10.1093/qjmed/hcab304/41787504/hcab304.pdf

Reference42 articles.

1. Antinuclear antibodies: clinical applications;Wanchu;J Postgrad Med,2000

2. Presentation of two bone marrow elements; the tart cell and the L.E. cell;Hargraves;Proc Staff Meet Mayo Clin,1948

3. Identification of the nuclear component of the interaction of lupus erythematosus globulin and nuclei;Friou;J Immunol (Baltimore Md.),1950

4. Clinical application of a test for lupus globulin-nucleohistone interaction using fluorescent antibody;Friou;Yale J Biol Med,1958

5. Improved method for measuring lupus globulin-nucleoprotein interaction;Friou;Proc Soc Exp Biol Med Soc Exp Biol Med N Y N,1958

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Exploration of Antinuclear Antibodies (ANAs): Unveiling Clinical Significance, Associations with Cancer, and the Nuances of Differential Diagnosis in Positive ANA Patients;Diagnostics;2024-02-01

2. Programmable Gravity Self‐Driven Microfluidic Chip for Point‐of‐Care Multiplied Immunoassays;Small;2023-12-12

3. Antinuclear antibodies in healthy population: Positive association with abnormal tissue metabolism, inflammation and immune dysfunction;International Immunopharmacology;2022-12

4. The Past, Present, and Future in Antinuclear Antibodies (ANA);Diagnostics;2022-03-07